These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Critical appraisal of revised cholesterol guidelines for the very high-risk patient. Rosenson R, Lloyd-Jones D, Working group from the Adult Treatment Panel III of the National Cholesterol Educational Program. Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256 [Abstract] [Full Text] [Related]
12. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002. Cullen MW, Stein JH, Gangnon R, McBride PE, Keevil JG. Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658 [Abstract] [Full Text] [Related]
13. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view. Crouch MA. J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369 [No Abstract] [Full Text] [Related]
14. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J. Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [Abstract] [Full Text] [Related]
15. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group. Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130 [Abstract] [Full Text] [Related]
16. Introduction: missing the target with lipid-lowering therapy. Hunninghake DB, McKenney JM. Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370 [No Abstract] [Full Text] [Related]
18. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS, Mikhailidis DP. Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [Abstract] [Full Text] [Related]
19. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [Abstract] [Full Text] [Related]